Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak - 19/01/21

Laurent Blairon ^a, Saphia Mokrane ^b, Alain Wilmet ^a, Géraldine Dessilly ^{c, d}, Benoît Kabamba-Mukadi ^{c, d}, Ingrid Beukinga ^a, Marie Tré-Hardy ^{a, e, f, ⁎}

^a Laboratory Medicine, Iris Hospitals South, Brussels, Belgium 

^b Infection Control, Iris Hospitals South, Brussels, Belgium 

^c Université Catholique de Louvain, Institute of Experimental and Clinical Research, Microbiology, Brussels, Belgium 

^d St-Luc University Hospital, Brussels, Belgium 

^e Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium 

^f Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Belgium 

^⁎Corresponding author at: Laboratory Medicine, Iris Hospitals South, 63 rue Jean Paquot, 1050, Brussels, Belgium.Laboratory MedicineIris Hospitals SouthBrusselsBelgium

Le texte complet de cet article est disponible en PDF.